Grace Halsey

500 S TRIMBLE RD

Articles

Lecanemab Monthly IV Maintenance Dosing: Research Highlights with R Scott Turner, PhD, MD

January 27, 2025

Georgetown University memory disorders expert R Scott Turner, PhD, MD, reviews the science behind approval of lecanemab for monthly maintenance dosing of lecanemab.

FDA Approves Monthly IV Maintenance Dosing of Lecanemab for Adults with Early Alzheimer Dementia: A First in Long-Term Disease Management

January 27, 2025

Once every four weeks maintenance dosing of lecanemab may be easier for patients and care partners to continue treatment.

3 Studies on Major Depressive Disorder: Physical, Pharmacologic, and Neuromodulatory Interventions Explored

January 24, 2025

Findings on the efficacy of treatments for MDD include the favorable effects of exercise, of CBT, and the robust outcomes of ECT among neuromodulatory modalities.

Anti-Amyloid Antibodies in Short: R Scott Turner, PhD, MD Explains

January 24, 2025

The revolutionary medications are the first new treatments for Alzheimer disease to be approved in more than 20 years and the first-ever disease-modifying drugs.

Vaccine Hesitancy in the Chronic Conditions Community: New Survey Findings

January 24, 2025

People with chronic diseases like COPD or with immunocompromising conditions continue to have reservations about vaccines against flu, COVID-19, and RSV.

Self-Reported Symptoms of Topical Steroid Withdrawal Identified in Study of Atopic Dermatitis

January 23, 2025

There are no diagnostic criteria for topical steroid withdrawal but patients describe and discuss it on social media. Study authors tapped a deep source of information.

Two Plasma Proteins May Serve as Early Biomarkers for Alzheimer Dementia and Help Explain Sex Differences, Study Suggests

January 23, 2025

Levels of acetyl-L-carnitine and free carnitine correlated significantly with disease severity, particularly in women with moderate and severe Alzheimer dementia.

Most People Who Monitor Health with Wearable Devices Don't Share Data with Clinicians

January 22, 2025

Only 25% of people who self-monitor health use the data to inform their physicians.

Landmark International Trial Seeks to Intercept and Prevent Crohn Disease Using Biomarkers

January 22, 2025

The INTERCEPT project aims to build a blood risk score that can identify individuals with a high risk of developing Crohn disease within 5 years of initial evaluation.

Attitudes Toward Vaccines in the Chronic Conditions Community: Survey Highlights

January 22, 2025

Hesitancy about vaccination against dangerous communicable diseases remains a public health problem, particularly when the hesitant are living with immunocompromising conditions.